test

Iris Isufi MD

Assistant Professor of Medicine (Hematology)

Clinical Interests

Bone Marrow Transplant; Stem Cell Transplant; Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma


Board Certifications

Hematology, Internal Medicine, Board Eligible
2011
Medical Oncology, Board Certified
2007
Internal Medicine, Board Certified

Patient Care Locations

iris_isufifaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Graft Versus Host Disease, Myelodysplastic Syndromes, Leukemia, not otherwise specified, and Non-Hodgkin's LymphomaA Multicenter, Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Leukemia, not otherwise specified and Myeloid and Monocytic LeukemiaA Phase 1-2, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects with Intermediate or High-Risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Lymphoid LeukemiaA Phase 1/2 Study of ISIS 481464, an Antisense Oligonucleotide Inhibitor of STAT3, Administered to Patients with Advanced Cancers
Non-Hodgkin's LymphomaA randomized, double-blind, placebo-controlled, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in the frontline treatment of patients with CD30- positive mature T-cell lymphomas

More Clinical Trials...

Edit Profile